_id
6911c51accc777a4e85d64db
Ticker
HKPD
Name
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Exchange
NASDAQ
Address
Well Town Industrial Building, Yau Tong, Hong Kong, 999077
Country
USA
Sector
Healthcare
Industry
Pharmaceutical Retailers
Currency
USD
Website
https://www.9zt.hk
Description
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Last Close
0.824
Volume
28258
Current Price
0.79
Change
-0.0176
Last Updated
2026-01-04T14:29:05.155Z
Image
data:image/webp;base64,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
Ipo Date
2025-01-15T00:00:00.000Z
Market Cap
8874800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.93
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
4611314
Cost Of Revenue
4356537
Gross Profit
254778
Operating Expenses
702277
Operating Income
-447500
Interest Expense
-
Pretax Income
-471375
Net Income
-427808
Eps
-0.04109208777904973
Dividends Per Share
-
Shares Outstanding
11000000
Income Tax Expense
43568
EBITDA
-396662
Operating Margin
-9.704392283847945
Total Other Income Expense Net
-23875
Cash
748721
Short Term Investments
2256830
Receivables
4713260
Inventories
559982
Total Current Assets
8727105
Property Plant Equipment
593734
Total Assets
9417276
Payables
1727809
Short Term Debt
864661
Long Term Debt
-
Total Liabilities
4427507
Equity
4989769
Bs_currency_symbol
-
Depreciation
315717
Change In Working Capital
81534
Cash From Operations
-91953
Capital Expenditures
14440
Cash From Investing
-1174310
Cash From Financing
1453569
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
1.6483041238983207
ROE
-8.573703512126512
ROA
-4.5427998499778495
FCF
-106393
Fcf Percent
-0.023072165547607472
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
4611314
Quarters > 0 > income Statement > cost Of Revenue
4356537
Quarters > 0 > income Statement > gross Profit
254778
Quarters > 0 > income Statement > operating Expenses
702277
Quarters > 0 > income Statement > operating Income
-447500
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-471375
Quarters > 0 > income Statement > net Income
-427808
Quarters > 0 > income Statement > eps
-0.04109208777904973
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10410958
Quarters > 0 > income Statement > income Tax Expense
43568
Quarters > 0 > income Statement > EBITDA
-396662
Quarters > 0 > income Statement > operating Margin
-9.704392283847945
Quarters > 0 > income Statement > total Other Income Expense Net
-23875
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
748721
Quarters > 0 > balance Sheet > short Term Investments
2256830
Quarters > 0 > balance Sheet > receivables
4713260
Quarters > 0 > balance Sheet > inventories
559982
Quarters > 0 > balance Sheet > total Current Assets
8727105
Quarters > 0 > balance Sheet > property Plant Equipment
593734
Quarters > 0 > balance Sheet > total Assets
9417276
Quarters > 0 > balance Sheet > payables
1727809
Quarters > 0 > balance Sheet > short Term Debt
864661
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4427507
Quarters > 0 > balance Sheet > equity
4989769
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-427808
Quarters > 0 > cash Flow > depreciation
315717
Quarters > 0 > cash Flow > change In Working Capital
81534
Quarters > 0 > cash Flow > cash From Operations
-91953
Quarters > 0 > cash Flow > capital Expenditures
14440
Quarters > 0 > cash Flow > cash From Investing
-1174310
Quarters > 0 > cash Flow > cash From Financing
1453569
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.04109208777904973
Quarters > 0 > ratios > PB
1.6483041238983207
Quarters > 0 > ratios > ROE
-8.573703512126512
Quarters > 0 > ratios > ROA
-4.5427998499778495
Quarters > 0 > ratios > FCF
-106393
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.023072165547607472
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
9222628
Quarters > 1 > income Statement > cost Of Revenue
8713074
Quarters > 1 > income Statement > gross Profit
509556
Quarters > 1 > income Statement > operating Expenses
1404554
Quarters > 1 > income Statement > operating Income
-895000
Quarters > 1 > income Statement > interest Expense
47750
Quarters > 1 > income Statement > pretax Income
-942750
Quarters > 1 > income Statement > net Income
-855616
Quarters > 1 > income Statement > eps
-0.08218417555809945
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
10410958
Quarters > 1 > income Statement > income Tax Expense
87136
Quarters > 1 > income Statement > EBITDA
-793324
Quarters > 1 > income Statement > operating Margin
-9.704392283847945
Quarters > 1 > income Statement > total Other Income Expense Net
-47750
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
748721
Quarters > 1 > balance Sheet > short Term Investments
2256830
Quarters > 1 > balance Sheet > receivables
4713260
Quarters > 1 > balance Sheet > inventories
559982
Quarters > 1 > balance Sheet > total Current Assets
8727105
Quarters > 1 > balance Sheet > property Plant Equipment
593734
Quarters > 1 > balance Sheet > total Assets
9417276
Quarters > 1 > balance Sheet > payables
1727809
Quarters > 1 > balance Sheet > short Term Debt
864661
Quarters > 1 > balance Sheet > long Term Debt
1503797
Quarters > 1 > balance Sheet > total Liabilities
4427507
Quarters > 1 > balance Sheet > equity
4989769
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-855616
Quarters > 1 > cash Flow > depreciation
631434
Quarters > 1 > cash Flow > change In Working Capital
163068
Quarters > 1 > cash Flow > cash From Operations
-183906
Quarters > 1 > cash Flow > capital Expenditures
28880
Quarters > 1 > cash Flow > cash From Investing
-2348620
Quarters > 1 > cash Flow > cash From Financing
2907138
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.08218417555809945
Quarters > 1 > ratios > PB
1.6483041238983207
Quarters > 1 > ratios > ROE
-17.147407024253024
Quarters > 1 > ratios > ROA
-9.085599699955699
Quarters > 1 > ratios > FCF
-212786
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.023072165547607472
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
4611314
Quarters > 2 > income Statement > cost Of Revenue
4356537
Quarters > 2 > income Statement > gross Profit
254778
Quarters > 2 > income Statement > operating Expenses
702277
Quarters > 2 > income Statement > operating Income
-447500
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-471375
Quarters > 2 > income Statement > net Income
-427808
Quarters > 2 > income Statement > eps
-0.04109208777904973
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
10410958
Quarters > 2 > income Statement > income Tax Expense
43568
Quarters > 2 > income Statement > EBITDA
-396662
Quarters > 2 > income Statement > operating Margin
-9.704392283847945
Quarters > 2 > income Statement > total Other Income Expense Net
-23875
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
748721
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4656031
Quarters > 2 > balance Sheet > inventories
559982
Quarters > 2 > balance Sheet > total Current Assets
8727105
Quarters > 2 > balance Sheet > property Plant Equipment
593734
Quarters > 2 > balance Sheet > total Assets
9417276
Quarters > 2 > balance Sheet > payables
1727924
Quarters > 2 > balance Sheet > short Term Debt
864661
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4427507
Quarters > 2 > balance Sheet > equity
4989769
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-427808
Quarters > 2 > cash Flow > depreciation
315717
Quarters > 2 > cash Flow > change In Working Capital
81534
Quarters > 2 > cash Flow > cash From Operations
-91953
Quarters > 2 > cash Flow > capital Expenditures
14440
Quarters > 2 > cash Flow > cash From Investing
-1174310
Quarters > 2 > cash Flow > cash From Financing
1453569
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.04109208777904973
Quarters > 2 > ratios > PB
1.6483041238983207
Quarters > 2 > ratios > ROE
-8.573703512126512
Quarters > 2 > ratios > ROA
-4.5427998499778495
Quarters > 2 > ratios > FCF
-106393
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.023072165547607472
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
11091190
Quarters > 3 > income Statement > cost Of Revenue
9185586
Quarters > 3 > income Statement > gross Profit
1905604
Quarters > 3 > income Statement > operating Expenses
878568
Quarters > 3 > income Statement > operating Income
1027036
Quarters > 3 > income Statement > interest Expense
48176
Quarters > 3 > income Statement > pretax Income
978862
Quarters > 3 > income Statement > net Income
828560
Quarters > 3 > income Statement > eps
0.082856
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10000000
Quarters > 3 > income Statement > income Tax Expense
150304
Quarters > 3 > income Statement > EBITDA
1059340
Quarters > 3 > income Statement > operating Margin
9.259926121543314
Quarters > 3 > income Statement > total Other Income Expense Net
-48174
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
364990
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
4895064
Quarters > 3 > balance Sheet > inventories
555522
Quarters > 3 > balance Sheet > total Current Assets
8879879
Quarters > 3 > balance Sheet > property Plant Equipment
1193264
Quarters > 3 > balance Sheet > total Assets
10162442
Quarters > 3 > balance Sheet > payables
1686245
Quarters > 3 > balance Sheet > short Term Debt
1142355
Quarters > 3 > balance Sheet > long Term Debt
1005610
Quarters > 3 > balance Sheet > total Liabilities
4810192
Quarters > 3 > balance Sheet > equity
5352250
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
828560
Quarters > 3 > cash Flow > depreciation
441938
Quarters > 3 > cash Flow > change In Working Capital
-897748
Quarters > 3 > cash Flow > cash From Operations
753120
Quarters > 3 > cash Flow > capital Expenditures
41036
Quarters > 3 > cash Flow > cash From Investing
-106344
Quarters > 3 > cash Flow > cash From Financing
-912024
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.082856
Quarters > 3 > ratios > PB
1.4760147601476017
Quarters > 3 > ratios > ROE
15.480592274277171
Quarters > 3 > ratios > ROA
8.153158463290614
Quarters > 3 > ratios > FCF
712084
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.06420266896518768
Quarters > 3 > health Score
71
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
20313818
Annuals > 0 > income Statement > cost Of Revenue
17898659
Annuals > 0 > income Statement > gross Profit
2415159
Annuals > 0 > income Statement > operating Expenses
2283121
Annuals > 0 > income Statement > operating Income
132038
Annuals > 0 > income Statement > interest Expense
97667
Annuals > 0 > income Statement > pretax Income
36112
Annuals > 0 > income Statement > net Income
-27056
Annuals > 0 > income Statement > eps
-0.0026511249496471456
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
10205479
Annuals > 0 > income Statement > income Tax Expense
63168
Annuals > 0 > income Statement > EBITDA
1207150
Annuals > 0 > income Statement > operating Margin
0.6499910553496148
Annuals > 0 > income Statement > total Other Income Expense Net
-95926
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
748721
Annuals > 0 > balance Sheet > short Term Investments
2256830
Annuals > 0 > balance Sheet > receivables
4713260
Annuals > 0 > balance Sheet > inventories
559982
Annuals > 0 > balance Sheet > total Current Assets
8727105
Annuals > 0 > balance Sheet > property Plant Equipment
593734
Annuals > 0 > balance Sheet > total Assets
9417276
Annuals > 0 > balance Sheet > payables
1727809
Annuals > 0 > balance Sheet > short Term Debt
864661
Annuals > 0 > balance Sheet > long Term Debt
1503797
Annuals > 0 > balance Sheet > total Liabilities
4427507
Annuals > 0 > balance Sheet > equity
4989769
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-27056
Annuals > 0 > cash Flow > depreciation
1073371
Annuals > 0 > cash Flow > change In Working Capital
-520246
Annuals > 0 > cash Flow > cash From Operations
569214
Annuals > 0 > cash Flow > capital Expenditures
154988
Annuals > 0 > cash Flow > cash From Investing
-2454963
Annuals > 0 > cash Flow > cash From Financing
1995114
Annuals > 0 > cash Flow > net Change In Cash
121864
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.0026511249496471456
Annuals > 0 > ratios > PB
1.6501325927512878
Annuals > 0 > ratios > ROE
-0.5422295100234099
Annuals > 0 > ratios > ROA
-0.2873017632699732
Annuals > 0 > ratios > FCF
414226
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.02039134149966294
Annuals > 0 > health Score
32
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
16688364
Annuals > 1 > income Statement > cost Of Revenue
13129699
Annuals > 1 > income Statement > gross Profit
3558665
Annuals > 1 > income Statement > operating Expenses
1950404
Annuals > 1 > income Statement > operating Income
1608261
Annuals > 1 > income Statement > interest Expense
82766
Annuals > 1 > income Statement > pretax Income
1525969
Annuals > 1 > income Statement > net Income
1329717
Annuals > 1 > income Statement > eps
0.18053144563149898
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
7365570
Annuals > 1 > income Statement > income Tax Expense
196252
Annuals > 1 > income Statement > EBITDA
2534311
Annuals > 1 > income Statement > operating Margin
9.63702014169873
Annuals > 1 > income Statement > total Other Income Expense Net
-82292
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
619575
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
3718728
Annuals > 1 > balance Sheet > inventories
933299
Annuals > 1 > balance Sheet > total Current Assets
7801710
Annuals > 1 > balance Sheet > property Plant Equipment
833693
Annuals > 1 > balance Sheet > total Assets
8667228
Annuals > 1 > balance Sheet > payables
1323135
Annuals > 1 > balance Sheet > short Term Debt
849701
Annuals > 1 > balance Sheet > long Term Debt
1119276
Annuals > 1 > balance Sheet > total Liabilities
4413569
Annuals > 1 > balance Sheet > equity
4253659
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1329717
Annuals > 1 > cash Flow > depreciation
925576
Annuals > 1 > cash Flow > change In Working Capital
-2648915
Annuals > 1 > cash Flow > cash From Operations
-394330
Annuals > 1 > cash Flow > capital Expenditures
88018
Annuals > 1 > cash Flow > cash From Investing
-40796
Annuals > 1 > cash Flow > cash From Financing
537315
Annuals > 1 > cash Flow > net Change In Cash
102644
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.18053144563149898
Annuals > 1 > ratios > PB
1.3970423759873558
Annuals > 1 > ratios > ROE
31.260545332853436
Annuals > 1 > ratios > ROA
15.341894778815096
Annuals > 1 > ratios > FCF
-482348
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.028903252589648692
Annuals > 1 > health Score
64
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
12555991
Annuals > 2 > income Statement > cost Of Revenue
9817066
Annuals > 2 > income Statement > gross Profit
2738925
Annuals > 2 > income Statement > operating Expenses
1695132
Annuals > 2 > income Statement > operating Income
1043793
Annuals > 2 > income Statement > interest Expense
23242
Annuals > 2 > income Statement > pretax Income
1020770
Annuals > 2 > income Statement > net Income
998196
Annuals > 2 > income Statement > eps
0.09074509090909091
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11000000
Annuals > 2 > income Statement > income Tax Expense
22574
Annuals > 2 > income Statement > EBITDA
1758598
Annuals > 2 > income Statement > operating Margin
8.31310726489052
Annuals > 2 > income Statement > total Other Income Expense Net
-23023
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
524613
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1697792
Annuals > 2 > balance Sheet > inventories
190887
Annuals > 2 > balance Sheet > total Current Assets
2748464
Annuals > 2 > balance Sheet > property Plant Equipment
654261
Annuals > 2 > balance Sheet > total Assets
3406754
Annuals > 2 > balance Sheet > payables
1400644
Annuals > 2 > balance Sheet > short Term Debt
419624
Annuals > 2 > balance Sheet > long Term Debt
116862
Annuals > 2 > balance Sheet > total Liabilities
2821512
Annuals > 2 > balance Sheet > equity
585242
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
998196
Annuals > 2 > cash Flow > depreciation
714586
Annuals > 2 > cash Flow > change In Working Capital
14297
Annuals > 2 > cash Flow > cash From Operations
1727079
Annuals > 2 > cash Flow > capital Expenditures
117705
Annuals > 2 > cash Flow > cash From Investing
-132095
Annuals > 2 > cash Flow > cash From Financing
-1155671
Annuals > 2 > cash Flow > net Change In Cash
439634
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.09074509090909091
Annuals > 2 > ratios > PB
15.16432518513709
Annuals > 2 > ratios > ROE
170.56123791525556
Annuals > 2 > ratios > ROA
29.30050129830331
Annuals > 2 > ratios > FCF
1609374
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.1281757847707919
Annuals > 2 > health Score
60
Valuation > metrics > PE
-0.04109208777904973
Valuation > metrics > PB
1.6483041238983207
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-8.573703512126512
Profitability > metrics > ROA
-4.902060878149168
Profitability > metrics > Net Margin
-0.09277355651773009
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8873170281029041
Risk > metrics > Interest Coverage
-5.989586818893633
Risk > final Score
24
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.366328250664424
Liquidity > metrics > Quick Ratio
3.150324979652609
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
100
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
70
Prev Risks > 0
-27
Prev Risks > 1
24
Prev Risks > 2
88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:58:07.740Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-08-14
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.08
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.08
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-28
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.08
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.08
Earnings History > 1 > surprise Percent
-
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWill HKPD stock see insider buying - Quarterly Portfolio Report & AI Enhanced Market Trend Forecasts bollywoodhelpline.com
Read more →How HKPD stock reacts to bond yields - Wall Street Watch & Pattern Based Trade Signal System bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.08
EPS Estimate
0
EPS Difference
-0.08
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.